Targeting , Combined Tumor Therapy Using Magnetic Graphene-Based Mesoporous
Yi Wang,Rongqin Huang,Guohai Liang,Zhengyong Zhang,Peng Zhang,Shaoning Yu,Jilie Kong
2013-01-01
Abstract:of a multifunctional nanomedicine. [ 1 ] Recently, sp 2 carbon nanomaterials, particularly graphene nanosheets, were found to possess extraordinary mechanical, electronic, and thermal properties and were investigated for applications in drug delivery, photothermal therapy, and biosensors. [ 2 ] In addition, to create graphene nanomedicine with additional properties and functions, such as targeting recognition or diagnosis, various biomolecules and inorganic nanoparticles have been conjugated on graphene surfaces. [ 3 ] All of these materials provided an opportunity for the preparation of a multifunctional graphene nanomedicine. However, dramatic improvements in current capabilities are still needed for practicable nanomedicine, [ 4 ] such as combining the different merits in one novel medicine and exerting their synergistic effect, [ 5 ] reducing the hydrophobicity and toxicity in biological systems of pristine graphene or reduced graphene oxide as therapeutic reagents, [ 6 ] improving the unstable release and loading capacity of anti-cancer drugs aroused by the weak π – π stacking interaction, [ 7 ] or enhancing the bonding capacity of different functional biomolecules. Few functional groups exist on the surfaces of pristine graphene or reduced graphene oxide, making them diffi cult to bind other molecules except via weak non-covalent adsorption. [ 8 ] As partially DOI: 10.1002/smll.201301297 Targeting peptide-modifi ed magnetic graphene-based mesoporous silica (MGMSPI) are synthesized, characterized, and developed as a multifunctional theranostic platform. This system exhibits many merits, such as biocompatibility, high near-infrared photothermal heating, facile magnetic separation, large T2 relaxation rates (r2), and a high doxorubicin (DOX) loading capacity. In vitro and in vivo results demonstrate that DOX-loaded MGMSPI (MGMSPID) can integrate magnetic resonance imaging, dualtargeting recognition (magnetic targeting and receptor-mediated active targeting), and chemo-photothermal therapy into a single system for a visualized-synergistic therapy of glioma. In addition, it is observed that the MGMSPID system has heat-stimulated, pH-responsive, sustained release properties. All of these characteristics would provide a robust multifunctional theranostic platform for visualized glioma therapy. Yi Wang , Rongqin Huang , Guohai Liang , Zhengyong Zhang , Peng Zhang , Shaoning Yu , and Jilie Kong * Theranostics